Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
New glass substrate is specially formulated for high-performance tablets, notebooks, and 8K TVs CORNING, N.Y.; MAY 13, 2019 - Corning Incorporated (NYSE: GLW) today introduced a new glass...
-
HAMILTON, Bermuda, May 13, 2019 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) (“Kiniksa”), a biopharmaceutical company focused on discovering, acquiring, developing and...
-
TITUSVILLE, Fla., May 10, 2019 (GLOBE NEWSWIRE) -- The Apple Rush Company, Inc. (OTC PINK: APRU) (the “company”) announces an agreement with AAG-Live, a worldwide premier event production company...
-
LEIDEN, Netherlands & CAMBRIDGE, Mass., May 08, 2019 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA...
-
TITUSVILLE, Fla., May 07, 2019 (GLOBE NEWSWIRE) -- The Apple Rush Company, Inc. (OTC PINK: APRU) (the “company”) announces the resignation of our lead sales rep and corporate wholesale trainer,...
-
VANCOUVER, Washington, April 29, 2019 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB: CYDY), CytoDyn, a late stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the...
-
TITUSVILLE, Fla., April 26, 2019 (GLOBE NEWSWIRE) -- The Apple Rush Company, Inc. (OTC PINK: APRU) (the “company”) Announces Fiscal Year 2018 Results. We are very excited to announce the following...
-
New York, April 23, 2019 (GLOBE NEWSWIRE) -- NASDAQ ANNOUNCES RESULTS FROM 2019 ANNUAL MEETING OF STOCKHOLDERS Apr 23, 2019 Download PDF Alfred W. Zollar, New Director, Elected to the Board and...
-
Alfred W. Zollar, New Director, Elected to the Board and Ten Directors Re-elected Nasdaq Board Re-elects Michael R. Splinter as Chairman of the Board NEW YORK, April 23, 2019 (GLOBE NEWSWIRE) --...
-
TORONTO and CAMBRIDGE, Mass., April 23, 2019 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company focused on the discovery and development of antibody...